EQUITY - Embodiment, social ineQualities, lifecoUrse epidemiology, cancer and chronIc diseases, intervenTions, methodologY
Equipe constitutive du CERPOP, UMR1295, unité mixte INSERM - Université Toulouse III Paul Sabatier
Nicolas FRANCHITTO •  chercheur



2024
  1. Elyn A, Roussin A, Lestrade C, Franchitto N, Jullian B, Cantagrel N. Low-dose ketamine infusion to facilitate opioid tapering in chronic non-cancer pain with opioid-use disorder: a historical cohort study. Reg Anesth Pain Med. 2024 Jun 11:rapm-2023-105035. doi: 10.1136/rapm-2023-105035. Epub ahead of print.
  2. Salles J, Eddiry S, Amri S, Galindo M, Lacassagne E, George S, Mialhe X, Lhuillier É, Franchitto N, Jeanneteau F, Gennero I, Salles JP, Tauber M. Differential DNA methylation in iPSC-derived dopaminergic neurons: a step forward on the role of SNORD116 microdeletion in the pathophysiology of addictive behavior in Prader-Willi syndrome. Mol Psychiatry. 2024 Apr 2. doi: 10.1038/s41380-024-02542-4. Epub ahead of print.
  3. Franchitto N, Bloch J, Solal C; French PCC Research Group; Pélissier F. Self-poisoning by E-cigarette and E-liquids: National Reports to French Poison Control Centers from July 2019 to December 2020: VIGIlance and VAPE: The VIGIVAPE Study. Nicotine Tob Res. 2024 Feb 22;26(3):281-288. doi: 10.1093/ntr/ntad116.
2023
  1. Franchitto N, Bloch J, Solal C; French PCC Research Group; Pélissier F. Self-poisoning by e-cigarette and e-liquids: national reports to French Poison Control Centers from July 2019 to December 2020: VIGIlance and VAPE: the VIGIVAPE Study. Nicotine Tob Res. 2023 Jul 9:ntad116. doi: 10.1093/ntr/ntad116.
2022
Pas de publications

2021
  1. Delcourt N, Arnich N, Sinno-Tellier S, Franchitto N. Mild paralytic shellfish poisoning (PSP) after ingestion of mussels contaminated below the European regulatory limit. Clin Toxicol (Phila). 2021 Jan;59(1):76-77. doi: 10.1080/15563650.2020.1788055.
     
  2. Dufayet L, Monnet F, Laborde-Casterot H, Caré W, Lekens B, Langrand J; French Poison Control Centers Research Network (Franchitto N. collaborator), Mégarbane B, Vodovar D. Unintentional exposure to pregabalin in ≤6-year-old children: a nationwide French Poison Control Center study. Clin Toxicol (Phila). 2021 May;59(5):433-439. doi: 10.1080/15563650.2020.1822530.
     
  3. Dufayet L, Care W, Deheul S, Laborde-Casterot H, Nisse P; French PCC Research Group (Franchitto N. collaborator), Langrand J, Vodovar D. Increase in pregabalin recreational use in adolescents in France. Clin Toxicol (Phila). 2021 Nov;59(11):1027-1030. doi: 10.1080/15563650.2021.1892719.
     
  4. Franchitto N. Cannabinoid hyperemesis syndrome in two French emergency departments: a prospective cohort. Fundam Clin Pharmacol. 2021 Feb;35(1):184-185. doi: 10.1111/fcp.12640.
     
  5. Franchitto N. Buprenorphine exposures in adolescents and adults: A 10-year experience of a French Poison Control Center. Editorial. Fundam Clin Pharmacol. 2021 Aug;35(4):762-763. doi: 10.1111/fcp.12714.
     
  6. Franchitto N. Épidémiologie des intoxications chez les enfants [Epidemiology of poisoning in children]. Rev Prat. 2021 Oct;71(8):894. French. PMID: 35147348.
     
  7. Franchitto N. Principales intoxications aiguës aux antalgiques [Main acute poisonings : analgesics]. Rev Prat. 2021 Nov;71(9):1021-1024. French. PMID: 35147325
     
  8. Franchitto N. Principales intoxications aiguës : Principes généraux de prise en charge, substances illicites et psychotropes, cardiotropes et monoxyde de carbone [Main acute poisonings : General principles of care, illicit and psychotropic substances, cardiotropic and carbon monoxide]. Rev Prat. 2021 Oct;71(8):895-904. French. PMID: 35147349.
     
  9. Franchitto N. Prise en charge systématisée d’un patient intoxiqué [Systematic management of an intoxicated patient]. Rev Prat. 2021 Nov;71(9):1018-1020. French. PMID: 35147324.
     
  10. Le Roux G, Sinno-Tellier S, Puskarczyk E, Labadie M, von Fabeck K, Pélissier F, Nisse P, Paret N; French PCC Research Group (Franchitto N collaborator), Descatha A, Vodovar D. Poisoning during the COVID-19 outbreak and lockdown: retrospective analysis of exposures reported to French poison control centres. Clin Toxicol (Phila). 2021 Sep;59(9):832-839. doi: 10.1080/15563650.2021.1874402.
     
  11. Salles J, Lacassagne E, Eddiry S, Franchitto N, Salles JP, Tauber M. What can we learn from PWS and SNORD116 genes about the pathophysiology of addictive disorders? Mol Psychiatry. 2021 Jan;26(1):51-59. doi: 10.1038/s41380-020-00917-x.
     
  12. Salles J, Eddiry S, Lacassagne E, Laurier V, Molinas C, Bieth É, Franchitto N, Salles JP, Tauber M. Patients with PWS and related syndromes display differentially methylated regions involved in neurodevelopmental and nutritional trajectory. Clin Epigenetics. 2021 Aug 13;13(1):159. doi: 10.1186/s13148-021-01143-0.
2020
  1. Delcourt N, Lanot T, Vardon-Bounes F, Gandia P, Franchitto N. Severe Metabolic Failures After Recreational Ingestion of γ-Butyrolactone. J Clin Psychopharmacol. 2020 Nov/Dec;40(6):624-626. doi: 10.1097/JCP.0000000000001276.
     
  2. Dufayet L, Monnet F, Laborde-Casterot H, Caré W, Lekens B, Langrand J; Mégarbane B, Vodovar D. French Poison Control Centers Research Network (Franchitto N collaborator). Unintentional exposure to pregabalin in ≤6-year-old children: a nationwide French Poison Control Center study. Clin Toxicol (Phila). 2020 Oct 2:1-7. doi: 10.1080/15563650.2020.1822530.
     
  3. Franchitto N. Buprenorphine poisoning in children: a 10-year experience of Marseille Poison Center. Fundam Clin Pharmacol. 2020;34(2):263‐264. doi:10.1111/fcp.12547.
     
  4. Franchitto N. Complications somatiques du cannabis [Cannabis use and somatic consequences]. Rev Prat. 2020 Jan;70(1):69-77. PMID: 32877036.
     
  5. Franchitto N. Methadone poisonings: a seven-year retrospective study of the French poison center network focusing on suicide attempt vs. misuses. Fundam Clin Pharmacol. 2020 Apr;34(2):288-289. doi: 10.1111/fcp.12545.
     
  6. Rolland B, Simon N, Franchitto N, Aubin HJ. France Grants an Approval to Baclofen for Alcohol Dependence. Alcohol Alcohol. 2020 Feb 7;55(1):44-45. doi: 10.1093/alcalc/agz08.
     
  7. Salles J, Mariaux N, Franchitto N, Sourdet S, Arbus C. Substance use disorder in the elderly and specified DSM-5 criteria. Geriatr Psychol Neuropsychiatr Vieil. 2020 Jun 1;18(2):197-204.  doi: 10.1684/pnv.2020.0858.
2019
  1. Jouanjus E, Lapeyre-Mestre M, Nodot M, Roussin A, Franchitto N, Boyes JP, Nasr N, Oustric S, Dupouy J. Teaching Basic Knowledge on Substance Use Disorders: The Impact of e-Learning on Health Professionals. Clin Ther. 2019 Oct;41(10):2154-2161. doi: 10.1016/j.clinthera.2019.07.012.
     
  2. de Beaurepaire R, Sinclair JMA, Heydtmann M, Addolorato G, Aubin HJ, Beraha EM, Caputo  F, Chick JD, de La Selle P, Franchitto N, Garbutt JC, Haber PS, Jaury P, Lingford-Hughes AR, Morley  KC, Müller CA, Owens L, Pastor A, Paterson LM, Pélissier F, Rolland B, Stafford  A, Thompson A, van den Brink  W , Leggio  L, Agabio  R. The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective. Front Psychiatry. 2019 Jan 4;9:708. doi: 10.3389/fpsyt.2018.00708.
     
  3. Karila L, Marillier M, Chaumette B, Billieux J, Franchitto N, Benyamina A. New synthetic opioids: Part of a new addiction landscape. Neurosci Neurosci Biobehav Rev. 2019 Nov;106:133-140. doi: 10.1016/j.neubiorev.2018.06.010.
     
  4. Labadie M, Rebouissoux L, Viala J, Nisse P, Vodovar D, Courtois A, Gallart JC , Glaizal M, Denoyelle F, Franchitto N, Manel J , Lamireau T, Puskarczyk E. Regarding pH-neutralizing esophageal irrigations as a novel mitigation strategy for button battery injury. Laryngoscope. 2019;129(4):E123‐E124. doi:10.1002/lary.27728.
     
  5. Vayr F, Herin F, Jullian B, Soulat JM, Franchitto N. Barriers to seeking help for physicians with substance use disorder: A review. Drug Alcohol Depend. 2019 Jun 1;199:116-121. doi: 10.1016/j.drugalcdep.2019.04.004.